*Please note this program does not test for facioscapulohumeral muscular dystrophy Type 1 (FSHD1), oculopharyngeal muscular dystrophy (OPMD), or myotonic dystrophy types 1 and 2.
United States, Canada, and Australia:
Test Requisition Form (US & Canada)
Test Requisition Form (Australia)*
Informed Patient Consent (English - US only)
Informed Patient Consent (English - Outside US)
Program Flyer (English)
*To order a test kit in Australia, please send an email to firstname.lastname@example.org with the requested kit type (saliva, blood, buccal), number of kits requested, sponsored testing program name, clinician name, email, phone number and address. If you're interested in shipping a saliva kit directly to a patient, please specify that in your email and include the patient's name and address.
Formulário de Solicitação em papel (Português)
Formulário de Consentimento Informado do Paciente (Português)
Folheto/Panfleto do Programa e Instruções para Pedidos no Brasil (Português)
Argentina, Chile, Colombia, Mexico:
Formulario de Solicitud de Prueba (Español)
Consentimiento Informado del Paciente (Español)
Folleto del Programa y Instrucciones de Pedido (Español)
If a positive result is identified, testing for your patient’s family members is available.
Simply follow the ordering instructions, selecting only the gene(s) you are interested in testing for the family member. The partner code will automatically be added with the order.
If you're a patient and believe you are eligible for this sponsored testing program, you have options:
Contact Genome Medical
(available in US only)
Schedule a genetic counseling session, by phone or video, with an expert who can review your testing options and place the order. There is no cost for Genome Medical services through the Detect Muscular Dystrophy program.
Find a local genetics provider
Search our genetics providers network to find a provider in your area. Please sign in, or create an account, to connect with our network of professionals. There may be a cost associated with the provider’s services.
For more than 65 years, MDA has committed to transforming the lives of individuals living with neuromuscular diseases through innovations in care and science. To learn more visit www.mda.org or call 1-833-ASK-MDA1.
Sanofi Genzyme is a sponsor of Detect Musuclar Dystrophy, helping increase access to genetic testing for eligibile patients in Australia.
Sarepta Therapeutics is a sponsor of Detect Musuclar Dystrophy, helping increase access to genetic testing for eligibile patients in the US and Canada.
Invitae is a genetic information company whose mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae provides clinical-grade, medically actionable genetic information to answer essential health questions across all stages of life.
While third parties and commercial organizations may provide financial support for this program, tests and services are performed by Invitae. Healthcare professionals must confirm that patients meet certain criteria to use the program. Third parties and commercial organizations may receive de-identified patient data from this program, but at no time would they receive patient identifiable information. Third parties and commercial organizations may receive contact information for healthcare professionals who use this program. Genetic testing is available in the US, Canada, Argentina, Australia, Brazil, Chile, Colombia, and Mexico. Healthcare professionals and patients who participate in this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use or support any other products or services from Invitae or from third parties or commercial organizations.